View all veterinary jobs
VetNurse.co.uk publishes a curated feed of veterinary nursing news for registered veterinary nurses (RVNs), students (SVNs) and veterinary nursing assistants, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest or professional significance — filtering out noise so busy veterinary nurses can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, referral and specialist settings, with a focus on issues affecting veterinary nurses in clinical and professional roles.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetNurse news by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
Movoflex contains eggshell membrane, hyaluronic acid, Astaxanthin, Boswellia serrata and krill meal, formulated to support joint health and help increase quality of life.
Virbac says that eggshell membrane, which has been shown to have an effect on mobility in dogs and humans1, contains a number of naturally occurring elements involved in joint structure and function, including collagen, glucosamine and chondroitin sulphate.
The company claims that one palatable Movoflex Soft Chew per day can lead to a perceived increase in mobility in 7 days 2, regardless of the activity levels or age of the dog.
This, the company says, compared to other supplements which can require multiple daily tablets to be given for up to six weeks before you start to see an effect.
Dan Johnson, Product Manager at Virbac said: ‘Movoflex Soft Chews offer pet owners an easy to give and reliable joint supplement, and as with all of Virbac’s joint health and mobility solutions, they are of the highest quality and developed based on science.’
Movoflex Soft Chews are available in Small (<15kg), Medium (15kg- 35kg) and Large Dog (35kg) packs, each containing 30 chews and are available to order from your usual veterinary wholesaler.
References
In the webinar, which is sponsored by Horiba, Ian will present an update on new exotic parasite infections and distribution across the UK and Europe, and what this means for pets, livestock and the people that care for them.
“New Exotic Parasites – Worming Their Way In?” is suitable for vets, nurses, students and veterinary care assistants.
https://horiba.link/4h2.
Backed by RJD Partners, the directors bought the company back from Benchmark Plc for a reported £12.75M after it decided to divest itself of all non-aquaculture-related assets.
Improve says that under its new leadership, it plans to expand its e-learning portfolio significantly, harnessing technologies like video teaching and virtual/augmented reality to offer a richer learning experience.
In collaboration with its assessment partner, the International School of Veterinary Postgraduate Studies (ISVPS), Improve will be developing new distance-learning programmes for veterinary nurses, including Anaesthesia and Surgical Nursing early in 2021.
Improve also plans further geographical expansion, including running programmes in languages including French, Spanish, German and Chinese.
Dr Heber Alves (pictured right) is Improve’s new CEO. He is supported by a management team that includes Improve founder Dr David Babington, Business Development Director and Mr John Douglass, UK Managing Director.
Heber said: “Improve is fully owned by a team of experienced veterinary and business professionals with a unique understanding of the profession’s training needs at a global level. Even better, we are backed by a private equity partner with a strong track record in professional education and a commitment to supporting our growth, both organically and through acquisition.
The company says AI Masses will allow veterinary professionals to analyse lesions suggestive of cancer in-clinic and with a fast turnaround.
The AI technology, which has been trained by human clinical pathologists, should enable individualised treatment outcomes earlier for more cases.
Zoetis says AI Masses only needs a single round of sample preparation and the results can, at additional cost, be supplemented with an expert review from a network of specialists through Zoetis’ Virtual Laboratory.
Dr. Richard Goldstein, DVM, DACVIM, DECVIM-CA, Global Chief Medical Officer at Zoetis said: “Waiting for results can be stressful for pet owners – even more so when it involves a cancer screening.
"Our research shows that up to 75% of pet owners find abnormal results highly stressful.1
"AI Masses is yet another point-of-care capability to deliver results in-clinic, further exemplifies Zoetis’ purpose to advance care for animals, shortening anxious wait times to allow for faster care decisions that help provide the best possible outcome.”
Pre-orders will be announced for US customers in Q2 2025.
VetSurgeon.org understands AI Masses will be coming to the UK some time in 2025.
https://www.zoetisdiagnostics.com
Reference
The app allows practices to submit results along with cytology and histopathology results in order to help train the AI algorithm and improve its accuracy from an original sensitivity of 85% and negative predictive value of 97%.
Liron Levy-Hirsch, Managing Director of HT Vista, said: “The HT app has provided us with over 700 additional validated scans to analyse this year alone.
"The validation process is well controlled, whereby we use the lab results to tag the scans as benign or malignant and let the algorithm know if it was correct or not.
"The more we train the algorithm the more accurate it becomes, and it is extremely exciting to see the sensitivity increase to 90% and the NPV to 98%.”
HT Vista says the app was developed to meet demand from clinics.
Liron said: "By having a portal to upload lab results alongside the device’s results not only do we further improve the device, but we also increase confidence among our vets and nurses that the device is a reliable tool.
https://ht-vista.uk
Faecal calprotectin is a calcium-binding protein released into the gut lumen predominantly by neutrophils, and to a lesser extent by monocytes and macrophages, during intestinal inflammation.
Its presence in faeces reflects the degree of neutrophilic infiltration in the gut mucosa, making it a useful biomarker for identifying intestinal inflammation.
Faecal calprotectin lateral flow testing is already used in human health and included in the NICE guidelines for the management of inflammatory bowel disease (IBD)1.
Determining the underlying cause of chronic diarrhoea, vomiting and weight loss in cats and dogs can be complex, often requiring invasive procedures such as endoscopy or biopsy - both of which carry cost, risk, and sometimes practical limitations in general practice.
GIQuest is designed to offer a non-invasive, rapid alternative to support clinical decision-making.
Carus says that whilst not a replacement for histopathology, faecal calprotectin concentrations have been shown to correlate with disease severity in dogs and cats, as measured by tools such as the Canine Chronic Enteropathy Clinical Activity Index (CCECAI).2
New data from the University of Bristol Vet School appears to confirm the test’s ability to differentiate dogs with histologically-confirmed inflammatory enteropathy from healthy controls with high sensitivity (94%) and specificity (96%) using a score threshold of 3mg/kg.2
Carus says the test also performed well in cats, distinguishing those with inflammatory enteropathy from healthy controls with a specificity of 100% and sensitivity of 92%.
In addition, the test detected elevated calprotectin levels consistent with inflammatory gastroenteropathy in 25% of dogs receiving oral NSAIDs, which highlights its potential not only in long-term monitoring but also early in treatment when GI side effects may first emerge.
Jolian Howell of Carus Animal Health said: “Faecal calprotectin testing can provide additional clarity in a range of clinical scenarios.
"It is particularly useful when diagnosing and managing suspected inflammatory enteropathy or food related reactions and for monitoring or screening for GI side effects of oral non-steroidal anti-inflammatories in long term OA therapy regimes.”
The Bristol study also showed that dogs with food-responsive enteropathy had a significant drop in calprotectin concentrations following dietary change, reinforcing the test’s role in tracking treatment response.
Georgie Louca, Veterinary Business Manager for Carus Animal Health, added: ”By providing a measurable, visual indicator of intestinal inflammation, GIQuest also helps support client communication and can improve compliance during treatment or dietary trials.”
GIQuest is designed for use in practice, including during consultations, delivering colour-coded results in 15 minutes.
GIQuest is now available to veterinary practices across the UK and can be ordered through veterinary wholesalers NVS, Covetrus and MWI.
https://carusanimalhealth.com/giquest
Reasonable adjustments can include changing working arrangements and providing equipment, services and support.
The campaign will address common myths and misconceptions surrounding reasonable adjustments and highlight the legal obligations of leaders and managers around implementation.
The campaign, which will run until the end of July, is being launched after an RCVS/British Veterinary Chronic Illness Support (BCVIS) survey concluded there is a need to increase awareness about reasonable adjustments, promote wider discussion and equip organisations with the information they need to implement them.
The research also indicated that improved knowledge of legislation is needed, with communication also being raised as an important issue, so that individuals feel empowered to ask for the support they need.
MMI Lead, Rapinder Newton, said: “Our ‘Let’s talk adjustments’ campaign will support people to have these important conversations by sharing information, educational resources and guidance on good practice.
"It will also provide examples of different types of adjustments, including examples that are specific to the veterinary context.
“We know that physical and mental health are deeply interconnected.
"Reasonable adjustments can support both physical and mental health but also helps to safeguard mental health through allowing individuals with disabilities to thrive.
“We will be keeping people updated on the campaign, which has its own dedicated section on the RCVS website, via the RCVS social media channels, as well as providing information in RCVS newsletters, so do keep an eye out for this over the coming months.”
https://www.rcvs.org.uk/lifelong-learning/leadership-diversity-and-inclusion/reasonable-adjustments-campaign/
Photo courtesy: https://depositphotos.com
Each event is designed to help attendees with:
Each attendee will be given a complimentary annual Veterinary Osteoarthritis Alliance (VOA) membership.
Kai Crawshaw, Animalcare Brand Manager said: "We had excellent feedback from our first workshops, so we’re pleased to be able to reach veterinary practices in more locations around the UK.
"We also have plans to run more across the rest of the year.
"We hope that these events will lead to veterinary staff becoming more confident in dealing with OA in dogs and helping owners understand the options open to them."
All events start at 7:30pm (arrival from 7pm) and will finish approximately at 9:30pm.
Hot food and drinks will be provided.
https://www.animalcare.co.uk/oa-workshops
There are four categories of award:
Veterinary practices who feel they have excellence to showcase are invited to submit their nominations via: https://spvs.org.uk/business-excellence-awards, highlighting why they deserve to receive the award against each of the selection criteria.
The deadline for nominations is 5pm on 31st October 2023.
The SPVS Board then will review submissions and shortlist the top 5 nominations in each category.
Shortlisted practices will be contacted by 5pm on the 15th November 2023, and invited to submit a more detailed statement of 750 words or a 90-second video, giving them another opportunity to showcase their accomplishments.
A panel of SPVS members will evaluate the final submissions and vote for a winner in each category.
Category winners will be announced before the end of the year, and will win full day + evening tickets to SPVS Congress 2024 on Thursday 25th January 2024 for three team members, plus overnight accommodation at the Hilton Birmingham Metropole.
The overall winner will be announced at the SPVS Congress 2024 opening ceremony (25th – 27th January 2024).
The project was launched in 2016 to identify and find solutions to some of the specific issues facing the veterinary nursing profession.
However, the organisations say that whilst they both want to make sure veterinary nursing remains a vibrant, rewarding and sustainable profession, they now recognise the benefits of the regulator and the representative body working more independently.
Lyndsay Hughes, BVNA President, said: “The joint decision to end the project marks an end of an era, but also the beginning of an exciting new chapter.
"We will continue to work with each other on activities and projects that support the veterinary nursing profession on an ongoing basis.”
To that end, the RCVS and BVNA have identified the need to continue to drive the effective use of veterinary nurses within the wider veterinary team, in order to promote job satisfaction, progression opportunities and excellent standards of patient care.
The BVNA published resources earlier this year designed to help maximise the RVN role within the current legislation, and there's a ‘RVN utilisation champions’ campaign launching later this year, and streams on the subject at BVNA Congress in October.
The association is also preparing a ‘Nurse Utilisation Toolkit’ which is due to launch in late 2025/early 2026 - to provide members with access to resources on how to implement and support effective use of nurses in the workplace.
The RCVS has recently launched the second phase of the VN Vision initiative which aims to inspire a cultural shift in how veterinary nurses can be more effectively integrated within multidisciplinary veterinary teams, and explore why doing so is essential for the future of veterinary healthcare.
A series of workshops ‘A vision or a necessity: strengthening the role of veterinary nurses in team-based veterinary healthcare’ is being held across the UK for all members of the veterinary team this year, with an additional session being held at BVNA Congress.
https://vnfutures.org.uk
Biomérieux says the new test, which is used on the Biofire Spotfire System, detects seven infectious respiratory pathogens (six viruses and/or a strain of bacteria*), from a nasopharyngeal swab, in under 20 minutes.
The company says the new test’s ability to distinguish between viral and bacterial infections is important for ensuring antibiotics are used appropriately to reduce the risk of resistance.
Biomérieux says VetFire can be used to make informed decisions about when to isolate and treat animals when respiratory infections are suspected, to mitigate the impact of an outbreak in a contained area, such as a yard, by allowing rapid quarantine measures, and perhaps in time as a standard test ahead of animals travelling for competition, to ensure they are fit and healthy.
VetFire is commercially available in United Kingdom, Ireland and France, with possible expansion plans to other countries in the near future.
https://www.biomerieux.com/corp/en/our-offer/clinical-products/vetfire.html
*Equine Herpesvirus type 1, Equine Herpesvirus type 4, Influenza A, Equine Rhinovirus A, Equine Rhinovirus B, Equine Adenovirus 1, Streptococcus equi equi
Practices which want to buy the alternative imported vaccine will need to apply to the VMD for a Special Import Certificate (SIC).
Wholesalers have agreed to stock the alternative vaccine.
Zoetis says it acknowledges the concern and frustration this causes its customers and wants to reassure the equine community that it is working hard to resume Equip Rotavirus supply as soon as possible.
For further information, contact your Zoetis account manager or ring Zoetis HQ on 0345 300 8034.
This, says the company, highlights the need for increased awareness of MCTs, which, accounting for up to 21% of skin cancer cases2 in dogs, are the most common form of canine cutaneous neoplasia.
The incidence of MCTs is highest in dogs aged 6 to 10 years old3,4 with predisposition in some of the UK’s most popular breeds such as Labradors, French Bulldogs, Staffordshire Bull Terriers and Golden Retrievers.
Virbac says that until the launch of Stelfonta, surgical removal of tumours was the standard of care, but surgery can pose challenges for the veterinary surgeon, such as the accessibility of the tumour in order to obtain sufficient margins and anaesthetic risks, particularly in senior and brachycephalic pets.
Apparently, however, 77% of delegates at London Vet Show said they were either likely or very likely to use Stelfonta on their next mast cell tumour case.
To help veterinary professionals and pet owners identify skin masses, Virbac has created a range of resources available at: vet-uk.virbac.com/stelfonta/education.
Vetlife's campaign included talks at various veterinary events, an awareness video, a series of lived experience blogs, and a downloadable resource for individuals and workplaces, all made possible by grant funding from the Zoetis Foundation.
Kirstie Pickles, Vetlife Trustee and project lead for the neurodiversity campaign said: “To be shortlisted was an honour, but to win this award is just incredible and is a testament to the dedication and passion that the team put into the campaign.
"It has been a pleasure and a privilege to lead this project and share this much needed information with the veterinary community.
"It is our hope that this campaign and its resources will enable and initiate discussions within teams to ensure that all within our wonderful veterinary professions can thrive."
https://www.vetlife.org.uk
1CPD was launched in 2020 with the aim of providing an easy-to-use platform for veterinary nurses to use to plan, record and reflect on their continuing professional development (CPD).
The workshops, which are taking place on Wednesday 9th December 2020, are designed to help those who are not yet familiar with the platform, or have some limited experience of it but would like some additional guidance.
The first workshop takes place at midday and is for those members of the profession who haven’t yet used the platform. The session will give an overview of how 1CPD works and the benefits of using it for planning, recording and reflecting on CPD. No prior knowledge is assumed, and complete beginners are especially welcome. There'll be an opportunity to ask questions.
The second workshop takes place at 7pm and is for those who have some experience of using 1CPD but may have further questions, for example, about how to use some of its features such as the planning module and how to best make use of the reflective notes and comments feature.
Both of the workshops will last for approximately an hour each.
Susan Paterson, Chair of the RCVS Education Committee, said: “We’ve seen fantastic take up of the 1CPD platform in less than a year – with around 65% of UK-practising veterinary surgeons and an amazing 80% of veterinary nurses using it to plan, record and reflect on their professional development. The feedback that we receive has been overwhelmingly positive, with the even the more technically-challenged amongst us finding 1CPD intuitive.
"Although the numbers are very encouraging, there is a cohort of people who have not yet actively engaged with the platform and maybe are unsure about using it or are put off by the thought of having to learn how to use a brand new online system. The aim of these workshops is to guide and reassure those who are hesitant that the 1CPD system is very simple and easy-to-use with lots of useful features. In the long run, it will save you a lot of time and effort when it comes to recording your CPD because it’s there on your phone or tablet, ready to update as-and-when you need to."
Richard Burley, Chief Technology Officer for the RCVS, added: “We are very glad that the 1CPD platform developed by our team here has been so well received. We are continuing to improve and update the platform based on user feedback to improve its design and usability and would welcome any further constructive comments that members of the professions have about it. We do hope you those who are both unfamiliar with the system, and those who have used it but need further advice, can join us for these sessions to find out both how to use 1CPD and how to get the best out of it.”
To sign up to one of the workshops, visit: www.rcvs.org.uk/news-and-views/events/1cpd-online-workshop.
For those who aren’t able to make it on the day, recorded versions of all of the workshops will be made available to watch again after the event.
To download 1CPD as an app for use on iOS (Apple) or Android devices, or to access the web version, visit: www.rcvs.org.uk/1CPD
Remember, you can record time spend helping each other on VetNurse.co.uk towards your annual CPD requirement. See: https://www.youtube.com/watch?v=bNia_du3PYw
Generally, veterinary practices may remain open, but there are national variations in what services should be offered and how, including the conditions under which remote prescribing can be used to help support a case.
Wales currently has the tightest ‘firebreak’ restrictions, meaning practices can only provide essential and urgent work until midnight on 8 November 2020, thereafter, returning to usual operations in line with Wales’ standard measures around workplace safety.
England and Northern Ireland are under national restrictions (4 Nov – 2 Dec, and 16 Oct – 12 Nov, respectively), meaning practices can provide treatment essential for maintaining animal health and welfare, along with non-urgent work providing that social distancing measures and safe working can be maintained.
Veterinary surgeons practising in these three countries may also choose to support a case remotely at an earlier stage, for example, through the remote prescribing of POM-Vs without first having conducted a physical examination.
Scotland remains the only country under regional tiered restrictions, meaning practices can continue to provide treatment whilst maintaining social distancing; however, before remote prescribing is offered, veterinary surgeons should first consider whether the animal can be brought under their care.
The full guidance and corresponding flowcharts should be consulted together and are available at www.rcvs.org.uk/covidfaq2and www.rcvs.org.uk/covidfaq4.
Typically, diagnosis of endocrine disease is based on a thorough history and physical examination, followed by laboratory tests.
However clinical signs vary substantially across animals with endocrine disorders, so this new app uses AI and big data from millions of dogs in the RVC VetCompass database to improve the chances of an accurate diagnosis.
Dr Dan O’Neill, Associate Professor for Companion Animal Epidemiology at the RVC, said: "By applying the latest AI technology, the app is designed to assist primary care veterinary surgeons to better detect and diagnose Cushing’s Syndrome.
"The app provides a guide to the probability of Cushing’s syndrome as an explanation in patients showing both typical and atypical clinical signs for Cushing’s"
The app is free to download on both Apple and Android devices in the UK and EU countries by searching for 'the endocrinology app".
John graduated from the RVC in 1973, after which his first job was at a mixed, mainly farm animal practice in Gloucestershire.
After returning to England, his first job was at a mixed, mainly farm animal practice in Gloucestershire.
From there he moved to a mixed equine/small animal practice in Maidstone before joining Pierson Stewart and Partners, of which he later became a partner and then sole owner. He sold the business in 2018.
John has lectured widely in veterinary dentistry, practice management and cardiology.
He continues to see cardiac cases and carry out breed heart certification.
John invented the word autobiology as it seemed befitting of a life in which animals and plants have been so intricately tied to his work as a veterinary surgeon and his hobbies of gardening and lawn tennis.
He said: "I hope anyone in the profession who is interested in the history of veterinary medicine will enjoy reading how much things have changed in the last 50 years.
"It also has something for anyone interested in practice management, business and finance, not to mention sport.
"I hope it might also help everyone think about their work life balance and mental well being.
"Or you might just enjoy the funny and sometimes tear-jerking anecdotes."
Autobiology of a Vet is priced at £15.99 (hardback) / £8.99 (paperback) / £6.99 (ebook).
For more information, visit: https://www.gbpublishing.co.uk/autobiology-of-a-vet
Annual renewal fees for veterinary nurses will remain at the same level as in 2021: £74.
The removal of the alternative fee payment arrangements means there will be no extension to the fee payment window for the 2022/23 fee year and the usual deadline of 31 December will apply.
RCVS Treasurer Niall Connell said: “We understand that many veterinary surgeons and veterinary nurses will have been impacted financially over the last couple of years, and we appreciate that this has been a very difficult time for the professions.
"We are pleased that we are able to keep fees static for a second year running, whilst maintaining a strong programme of strategic projects that help to set, uphold and advance standards within the professions.”
Canine Arthritis Management says the service is designed to help address issues with the traditional veterinary care approach, such as short consult times, significant workplace pressure and lack of understanding of the caregiver.
The service offers expert consultations through which veterinary professionals and other caregivers can confer with a dedicated team of experts in canine arthritis for the latest insights and treatment strategies.
The telehealth service can also supplement the veterinary consultation, giving extra time to create personalised care plans for clients, tailored to their dog's specific needs.
Canine Arthritis Management says its care plans are designed with a holistic approach, considering not only the medical requirements of the dog but also its living environment and lifestyle.
Canine Arthritis Telehealth also offers ongoing support and educational resources.
Canine Arthritis Management Founder, Hannah Capon MRCVS said: “One of the biggest misunderstandings surrounding osteoarthritis is that it is simple to manage.
"It is not.
"The long term, waxing and waning nature of the disease, combined with the financial and physical commitments, leads to emotional exhaustion for the caregiver.
"Combining this with a lack of understanding of the disease, confusion regarding the myriad of ways to address it, and anxiety surrounding the future, caregivers of animals with chronic disease need more support, and that is exactly what this service offers.”
caninearthritisteleguidance.co.uk
Francisco says he decided to launch the podcast after watching how the bond between society and veterinary professionals has been eroded in recent years, with vets increasingly being portrayed as money-grabbers and uncaring in the press.
The aim of the podcast is to show the human behind the surgical mask; that veterinary professionals have the same feelings, motivations, worries and passions as anyone else.
Francisco said: "For those who aren’t part of the veterinary community, I hope to open a window into who we are, so they can better understand what drives our behaviours, decisions and compassion. And for those who are, I hope to make them feel that they’re not alone."
More Than Just a Vet is open for everyone to listen to directly from the website morethanjustavet.net, where you can subscribe to be alerted when there's a new release. The podcast is also available on all major podcast providers.
Brainchild of Tom Towey MRCVS, an ECC clinician, the new service allows vets to upload case details, including the level of urgency, and then browse the referral centres that can meet the need, listed by the distance to the practice or to the client and the level of expertise available (eg. Specialist / Advanced Veterinary Practitioner).
The vet then selects the ones that look interesting, presses submit, and the request is sent on their behalf.
The referral practices they've contacted can then reply with their estimate for the procedure and details of when they can see the case.
The owner is notified about each new estimate and can decide which to accept.
When they do, the referral clinic then calls the owner to make an appointment.
Tom highlights part of the Competition and Markets Authority provisional report which says:
"10.16: Our provisional view is that, in a well-functioning market, where multiple referral providers are available and clinically appropriate, we would expect pet owners to be made aware that they can choose a referral provider and to be able to access information about those providers including the nature of the treatment, the skills and experience of the referral vet, the availability of appointments, and, in many cases, the likely cost."
Tom's new service seems to fit the bill precisely.
www.rapidreferrals.co.uk
The authors say that whilst it has long been suspected that adverse drug reactions are under-reported, this study is the first to show the scale of the problem, using real data from veterinary clinical records.
For the study, researchers looked for electronic heath records within the Small Animal Veterinary Surveillance Network (SAVSNET) which contained “adverse drug reactions” and “side effects” in the free-text clinical narratives.
The results were then analysed to determine the suspected product, the seriousness and expectedness of the event, and whether the event had been reported to the Veterinary Medicines Directorate or Marketing Authorisation Holders.
Of the 827 cases of suspected adverse drug reactions identified out of a total of 10,565 records reviewed, approximately 90% were not reported.
74% were related to dogs and 70% were listed as “expected” (i.e. already listed in the product information).
The clinical severity of the reaction didn’t appear to impact whether it was reported.
Dr Heather Davies, lead author of the study, said: “As adverse drug reaction reporting rate is directly linked to the regulators ability to mitigate safety issues, this paper is a call to arms encouraging all veterinary professionals to report suspected adverse drug reactions and regulators to make reporting quicker and easier.
"It also the highlights the promise that big real-world data sets hold in enhancing drug safety monitoring processes.”
https://onlinelibrary.wiley.com/doi/full/10.1111/jsap.13721
The guides have been developed for vet teams to share with their clients and work through together, so that both sides are on the same page about owner values, pet welfare and behaviour, and diagnosis and treatment options.
A member of the veterinary team and the client can then work together to make decisions and provide quality care.
One of the pet owners who helped develop the guides said: “I always get so worked up with vet consultations that I forget half of what they say, or feel like I didn’t tell them enough about my pet’s history.
"If the vet used these guides at my next consult, they would make me feel very at ease indeed!”
Pam Mosedale, Clinical Lead at RCVS Knowledge, said: “These guides offer a simple, actionable way to help deliver contextualised care in practice.
"To get started, run through the questions in the guide with a client, and see how this can help you devise a treatment plan with the information you’ve discovered.
"This helps you gain a fuller understanding of your patient’s care and wellbeing needs and your client’s circumstances and expectations.
"Ultimately, this will assist you in delivering quality care that aligns with the needs and expectations of your clients.”
There are three contextualised care discussion guides:
RCVS Knowledge is encouraging veterinary teams to adapt the guides to meet their individual needs.
https://rcvsknowledge.org/contextualisedcare
COMMENT
Anything which helps clear communication between the owner and vet is surely to be applauded, and if owners are prepared to spend the time completing the pre-consultation guide, it would surely leave less room for error.
However, arguably the greatest cause of friction between owners and vets is cost, and that is something only mentioned fleetingly, in the context of: 'Are there any other factors that may impact on the care of your pet? e.g planned holidays or financial concerns'.
Isn't it time to stop beating around the bush?
Isn't there an opportunity here for greater clarity over the level of spending a client is happy with?
Is there an acceptable form of words here to ascertain whether - regardless of whether they have financial concerns or not - the client is one of those who wants the cheapest solution to the problem, one for whom money is no object, or someone who sits somewhere in the middle?
Wouldn't that be more instructive than almost anything else?
Vet-AI's automated triage app offers instant advice to pet owners 24/7, early detection of health issues and advice as to whether they need to speak to a vet.
For the blinded test, which was conducted in April 2025, three UK veterinary surgeons reviewed the responses from Vet-AI, Gemini 2.0 and ChatGPT 4.0 to 48 simulated enquiries from owners.
The vets evaluated each on clinical accuracy, triage effectiveness and the subjective criteria of factuality, integrity, safety, empathy and readability.
Vet-AI’s Large Language Model (LLM) achieved an accuracy score of 81%, surpassing Gemini (69%) and ChatGPT (50%).
Vet-AI’s model also stopped triage at the correct point in 81% of cases according to the vets, compared with Gemini’s 75% and ChatGPT’s 56%.
Vet-AI’s tool also outperformed the leading LLMs on subjective measures, delivering more empathetic, thorough and factual responses to pet owners.
Samantha Webster, Chief Veterinary Officer at Vet-AI said: “These latest results are a significant milestone in the development of automated triage.
"We’re proving we can provide trustworthy online pet care by combining clinical and technical expertise.
"This tool can support the wider industry too, engaging more pet owners in the first step of vet care, ensuring their pets get the care they need - whether in practice or remotely.
"We know that an increasing percentage of the UK pet population is struggling to access veterinary care.
"Whilst AI will never replace a vet, the use of innovative technology can break down the barrier to access, leading to more pets getting the care they need, when they need it."
“With this level of clinical accuracy and technical innovation, we're helping to bring great pet care to more people. As well as helping to create more demand for vet services by making the triage of pets as accurate as possible,” said Paul Hallett, Vet-AI founder and exec chair.
https://www.vet-ai.com/automated-triage